Cargando…

Repression of human activation induced cytidine deaminase by miR-93 and miR-155

BACKGROUND: Activation Induced cytidine Deaminase (AID) targets the immunoglobulin genes of activated B cells, where it converts cytidine to uracil to induce mutagenesis and recombination. While essential for immunoglobulin gene diversification, AID misregulation can result in genomic instability an...

Descripción completa

Detalles Bibliográficos
Autores principales: Borchert, Glen M, Holton, Nathaniel W, Larson, Erik D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3163633/
https://www.ncbi.nlm.nih.gov/pubmed/21831295
http://dx.doi.org/10.1186/1471-2407-11-347
_version_ 1782210974546132992
author Borchert, Glen M
Holton, Nathaniel W
Larson, Erik D
author_facet Borchert, Glen M
Holton, Nathaniel W
Larson, Erik D
author_sort Borchert, Glen M
collection PubMed
description BACKGROUND: Activation Induced cytidine Deaminase (AID) targets the immunoglobulin genes of activated B cells, where it converts cytidine to uracil to induce mutagenesis and recombination. While essential for immunoglobulin gene diversification, AID misregulation can result in genomic instability and oncogenic transformation. This is classically illustrated in Burkitt's lymphoma, which is characterized by AID-induced mutation and reciprocal translocation of the c-MYC oncogene with the IgH loci. Originally thought to be B cell-specific, AID now appears to be misexpressed in several epithelial cancers, raising the specter that AID may also participate in non-B cell carcinogenesis. METHODS: The mutagenic potential of AID argues for the existence of cellular regulators capable of repressing inappropriate AID expression. MicroRNAs (miRs) have this capacity, and we have examined the publically available human AID EST dataset for miR complementarities to the human AID 3'UTR. In this work, we have evaluated the capacity of two candidate miRs to repress human AID expression in MCF-7 breast carcinoma cells. RESULTS: We have discovered moderate miR-155 and pronounced miR-93 complementary target sites encoded within the human AID mRNA. Luciferase reporter assays indicate that both miR-93 and miR-155 can interact with the 3'UTR of AID to block expression. In addition, over-expression of either miR in MCF-7 cells reduces endogenous AID protein, but not mRNA, levels. Similarly indicative of AID translational regulation, depletion of either miR in MCF-7 cells increases AID protein levels without concurrent increases in AID mRNA. CONCLUSIONS: Together, our findings demonstrate that miR-93 and miR-155 constitutively suppress AID translation in MCF-7 cells, suggesting widespread roles for these miRs in preventing genome cytidine deaminations, mutagenesis, and oncogenic transformation. In addition, our characterization of an obscured miR-93 target site located within the AID 3'UTR supports the recent suggestion that many miR regulations have been overlooked due to the prevalence of truncated 3'UTR annotations.
format Online
Article
Text
id pubmed-3163633
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-31636332011-08-31 Repression of human activation induced cytidine deaminase by miR-93 and miR-155 Borchert, Glen M Holton, Nathaniel W Larson, Erik D BMC Cancer Research Article BACKGROUND: Activation Induced cytidine Deaminase (AID) targets the immunoglobulin genes of activated B cells, where it converts cytidine to uracil to induce mutagenesis and recombination. While essential for immunoglobulin gene diversification, AID misregulation can result in genomic instability and oncogenic transformation. This is classically illustrated in Burkitt's lymphoma, which is characterized by AID-induced mutation and reciprocal translocation of the c-MYC oncogene with the IgH loci. Originally thought to be B cell-specific, AID now appears to be misexpressed in several epithelial cancers, raising the specter that AID may also participate in non-B cell carcinogenesis. METHODS: The mutagenic potential of AID argues for the existence of cellular regulators capable of repressing inappropriate AID expression. MicroRNAs (miRs) have this capacity, and we have examined the publically available human AID EST dataset for miR complementarities to the human AID 3'UTR. In this work, we have evaluated the capacity of two candidate miRs to repress human AID expression in MCF-7 breast carcinoma cells. RESULTS: We have discovered moderate miR-155 and pronounced miR-93 complementary target sites encoded within the human AID mRNA. Luciferase reporter assays indicate that both miR-93 and miR-155 can interact with the 3'UTR of AID to block expression. In addition, over-expression of either miR in MCF-7 cells reduces endogenous AID protein, but not mRNA, levels. Similarly indicative of AID translational regulation, depletion of either miR in MCF-7 cells increases AID protein levels without concurrent increases in AID mRNA. CONCLUSIONS: Together, our findings demonstrate that miR-93 and miR-155 constitutively suppress AID translation in MCF-7 cells, suggesting widespread roles for these miRs in preventing genome cytidine deaminations, mutagenesis, and oncogenic transformation. In addition, our characterization of an obscured miR-93 target site located within the AID 3'UTR supports the recent suggestion that many miR regulations have been overlooked due to the prevalence of truncated 3'UTR annotations. BioMed Central 2011-08-10 /pmc/articles/PMC3163633/ /pubmed/21831295 http://dx.doi.org/10.1186/1471-2407-11-347 Text en Copyright ©2011 Borchert et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Borchert, Glen M
Holton, Nathaniel W
Larson, Erik D
Repression of human activation induced cytidine deaminase by miR-93 and miR-155
title Repression of human activation induced cytidine deaminase by miR-93 and miR-155
title_full Repression of human activation induced cytidine deaminase by miR-93 and miR-155
title_fullStr Repression of human activation induced cytidine deaminase by miR-93 and miR-155
title_full_unstemmed Repression of human activation induced cytidine deaminase by miR-93 and miR-155
title_short Repression of human activation induced cytidine deaminase by miR-93 and miR-155
title_sort repression of human activation induced cytidine deaminase by mir-93 and mir-155
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3163633/
https://www.ncbi.nlm.nih.gov/pubmed/21831295
http://dx.doi.org/10.1186/1471-2407-11-347
work_keys_str_mv AT borchertglenm repressionofhumanactivationinducedcytidinedeaminasebymir93andmir155
AT holtonnathanielw repressionofhumanactivationinducedcytidinedeaminasebymir93andmir155
AT larsonerikd repressionofhumanactivationinducedcytidinedeaminasebymir93andmir155